MY148277A - Treatment of cartilage disorders with fgf-18 - Google Patents
Treatment of cartilage disorders with fgf-18Info
- Publication number
- MY148277A MY148277A MYPI20090702A MYPI20090702A MY148277A MY 148277 A MY148277 A MY 148277A MY PI20090702 A MYPI20090702 A MY PI20090702A MY PI20090702 A MYPI20090702 A MY PI20090702A MY 148277 A MY148277 A MY 148277A
- Authority
- MY
- Malaysia
- Prior art keywords
- treatment
- fgf
- osteoarthritis
- cartilage disorders
- cartilage disorder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
THIS INVENTION CONCERNS THE TREATMENT OF CARTILAGE DISORDER AND OSTEOARTHRITIS IN PARTICULAR. MORE SPECIFICALLY, IT RELATES TO THE USE OF FGF-18 IN TREATMENT REGIMENS AND FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PATIENTS HAVING A CARTILAGE DISORDER SUCH AS OSTEOARTHRITIS, SUCH AS FOR EXAMPLE KNEE OSTEOARTHRITIS OR SECONDARY HIP OSTEOARTHRITIS. SPECIFICALLY PROVIDED IS A PREFERRED TREATMENT SCHEME COMPRISING ONCE WEEKLY ADMINISTRATION OF AN FGF-18 COMPOUND PER TREATMENT CYCLE.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06119557 | 2006-08-25 | ||
US84060006P | 2006-08-28 | 2006-08-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
MY148277A true MY148277A (en) | 2013-03-29 |
Family
ID=37684849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI20090702A MY148277A (en) | 2006-08-25 | 2007-08-24 | Treatment of cartilage disorders with fgf-18 |
Country Status (11)
Country | Link |
---|---|
CN (1) | CN101505787B (en) |
BR (1) | BRPI0715728A8 (en) |
DK (1) | DK2054050T3 (en) |
ES (1) | ES2392883T3 (en) |
MY (1) | MY148277A (en) |
NZ (1) | NZ574216A (en) |
PT (1) | PT2054050E (en) |
RS (1) | RS52710B (en) |
SI (1) | SI2054050T1 (en) |
UA (1) | UA99818C2 (en) |
ZA (1) | ZA200900426B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2660818T3 (en) * | 2012-08-06 | 2018-03-26 | Merck Patent Gmbh | Genetic markers to predict the responsiveness to a compound of FGF-18 |
SI3107559T1 (en) * | 2014-02-20 | 2018-11-30 | Merck Patent Gmbh | Fgf-18 compound dosing regimen |
CN106232153B (en) * | 2014-02-20 | 2020-01-17 | 默克专利有限公司 | FGF-18 for transplantation and tissue engineering surgery |
PT3107592T (en) * | 2014-02-20 | 2018-12-03 | Merck Patent Gmbh | Implant comprising fgf-18 |
CN107405388A (en) * | 2015-01-08 | 2017-11-28 | 衣阿华大学研究基金会 | Method for internal Regeneration of Articular Cartilage |
EP3322736B1 (en) | 2015-07-15 | 2021-09-01 | Prosit Sole Biotechnology (Beijing) Co., Ltd | Fusion polypeptides and methods of use |
AU2016306626A1 (en) * | 2015-08-13 | 2018-02-22 | Merck Patent Gmbh | Combination composition comprising FGF-18 compound |
JP2023502520A (en) * | 2019-11-21 | 2023-01-24 | リミディアム バイオ,インコーポレーテッド | growth factor recovery |
US11904006B2 (en) | 2019-12-11 | 2024-02-20 | University Of Iowa Research Foundation | Poly(diaminosulfide) particle-based vaccine |
CN117721115A (en) * | 2022-09-06 | 2024-03-19 | 深圳瑞吉生物科技有限公司 | mRNA for treating osteoarthritis and preparation method and application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003279835B2 (en) * | 2002-10-07 | 2009-09-10 | Zymogenetics, Inc. | Methods of administering FGF18 |
EP2327413A1 (en) * | 2004-07-06 | 2011-06-01 | ZymoGenetics, Inc. | Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use |
PT1828239E (en) * | 2004-12-10 | 2011-10-27 | Zymogenetics Inc | Fgf18 production in prokaryotic hosts |
-
2007
- 2007-08-24 ES ES07802876T patent/ES2392883T3/en active Active
- 2007-08-24 NZ NZ574216A patent/NZ574216A/en unknown
- 2007-08-24 DK DK07802876.8T patent/DK2054050T3/en active
- 2007-08-24 ZA ZA200900426A patent/ZA200900426B/en unknown
- 2007-08-24 MY MYPI20090702A patent/MY148277A/en unknown
- 2007-08-24 RS RS20120483A patent/RS52710B/en unknown
- 2007-08-24 UA UAA200902217A patent/UA99818C2/en unknown
- 2007-08-24 BR BRPI0715728A patent/BRPI0715728A8/en not_active Application Discontinuation
- 2007-08-24 SI SI200731047T patent/SI2054050T1/en unknown
- 2007-08-24 PT PT07802876T patent/PT2054050E/en unknown
- 2007-08-24 CN CN2007800312016A patent/CN101505787B/en active Active
Also Published As
Publication number | Publication date |
---|---|
UA99818C2 (en) | 2012-10-10 |
ZA200900426B (en) | 2010-04-28 |
CN101505787A (en) | 2009-08-12 |
PT2054050E (en) | 2012-09-17 |
DK2054050T3 (en) | 2012-09-03 |
BRPI0715728A2 (en) | 2013-09-17 |
BRPI0715728A8 (en) | 2018-04-03 |
CN101505787B (en) | 2013-09-04 |
SI2054050T1 (en) | 2012-12-31 |
RS52710B (en) | 2013-08-30 |
ES2392883T3 (en) | 2012-12-14 |
NZ574216A (en) | 2011-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008023063A3 (en) | Treatment of cartilage disorders with fgf-18 | |
MY148277A (en) | Treatment of cartilage disorders with fgf-18 | |
MY150702A (en) | Substituted 4-phenyltetrahydroisoquinonelines, method of producing them, their use as medicament, and also medicament containing them | |
TW200800976A (en) | New compounds for the treatment of neurological, psychiatric or pain disorders | |
TW200716672A (en) | Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same | |
MX337575B (en) | Sulphone compounds for use in the treatment of obesity. | |
HK1085140A1 (en) | Pharmaceutical compositions and method of using levodopa and carbidopa | |
IL201479A (en) | Use of tapentadol for the manufacture of a medicament for the treatment of pain | |
MY162067A (en) | Combination therapy for treatment of patients with neurological disorders and cerebral infarction | |
TW200734334A (en) | Treatment of substance abuse | |
UA85471C2 (en) | Use of oxycodone for treating visceral pain | |
UA104988C2 (en) | Novel pyrone-indole derivatives and process for their preparation | |
NZ597419A (en) | Formulations for the treatment of deep tissue pain | |
TNSN07263A1 (en) | Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them | |
WO2008052139A3 (en) | Ultra low dose doxepin and methods of using the same to treat sleep disorders | |
MX2012007813A (en) | Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent. | |
WO2007134326A3 (en) | Methods for treating autoimmune diseases using a taci-ig fusion molecule | |
NZ591496A (en) | A medicinal comprising ibuprofen and paracetamol and treatment for arthritis | |
MX2009003532A (en) | Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin. | |
EA201070193A1 (en) | TREATMENT OF CHILDREN'S TUMORS | |
IL198202A0 (en) | Peptide-cytotoxic conjugates | |
MY146657A (en) | Use of 4-cyclopropylmethoxy-n- (3,5-dichloro-1-oxido-pyridin-4-yl)-5-(methoxy) pyridine-2-carboxamide for the treatment of spinal cord traumas | |
MX2008013477A (en) | Bicyclic tetrahydropyrrole compounds. | |
WO2010072774A3 (en) | 5-ht2a and 5-ht2b receptor antagonists for treating stenosis of the spinal canal | |
MX2009011214A (en) | Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin -4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of cranial traumas. |